Literature DB >> 30725336

A Machine-Learning Algorithm to Optimise Automated Adverse Drug Reaction Detection from Clinical Coding.

Christopher McMaster1,2, David Liew3,4, Claire Keith5, Parnaz Aminian5, Albert Frauman3,4.   

Abstract

INTRODUCTION: Adverse drug reaction (ADR) detection in hospitals is heavily reliant on spontaneous reporting by clinical staff, with studies in the literature pointing to high rates of underreporting [1]. International Classification of Diseases, 10th Revision (ICD-10) codes have been used in epidemiological studies of ADRs and offer the potential for automated ADR detection systems.
OBJECTIVE: The aim of this study was to develop an automated ADR detection system based on ICD-10 codes, using machine-learning algorithms to improve accuracy and efficiency.
METHODS: For a 12-month period from December 2016 to November 2017, every inpatient episode receiving an ICD-10 code in the range Y40.0-Y59.9 (ADR code) was flagged for review as a potential ADR. Each flagged admission was assessed by an expert pharmacist and, if needed, reviewed at regular ADR committee meetings. For each report, a determination was made about ADR probability and severity. The dataset was randomly split into training and test sets. A machine-learning model using the random forest algorithm was developed on the training set to discriminate between true and false ADR reports. The model was then applied to the test set to assess accuracy using the area under the receiver operating characteristic (AUC).
RESULTS: In the study period, 2917 Y40.0-Y59.9 codes were applied to admissions, resulting in 245 ADR reports after review. These 245 reports accounted for 44.5% of all ADR reporting in our hospital in the study period. A random forest model built on the training set was able to discriminate between true and false reports on the test set with an AUC of 0.803.
CONCLUSIONS: Automated ADR detection using ICD-10 coding significantly improved ADR detection in the study period, with improved discrimination between true and false reports by applying a machine-learning model.

Mesh:

Year:  2019        PMID: 30725336     DOI: 10.1007/s40264-018-00794-y

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  10 in total

1.  Demystifying medication safety: making sense of the terminology.

Authors:  Stacy Ackroyd-Stolarz; Nicole Hartnell; Neil J Mackinnon
Journal:  Res Social Adm Pharm       Date:  2006-06

2.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

Review 3.  Pharmacovigilance and expedited drug approvals.

Authors:  Matthew Linger; Jennifer Martin
Journal:  Aust Prescr       Date:  2018-04-03

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  Diagnosis-based and external cause-based criteria to identify adverse drug reactions in hospital ICD-coded data: application to an Australia population-based study.

Authors:  Wei Du; Sallie-Anne Pearson; Nicholas A Buckley; Cathy Day; Emily Banks
Journal:  Public Health Res Pract       Date:  2017-04-27

6.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

7.  Systematic review of predictive risk models for adverse drug events in hospitalized patients.

Authors:  Nazanin Falconer; Michael Barras; Neil Cottrell
Journal:  Br J Clin Pharmacol       Date:  2018-02-22       Impact factor: 4.335

Review 8.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

9.  Perceived barriers to reporting adverse drug events in hospitals: a qualitative study using theoretical domains framework approach.

Authors:  Fariba Mirbaha; Gloria Shalviri; Bahareh Yazdizadeh; Kheirollah Gholami; Reza Majdzadeh
Journal:  Implement Sci       Date:  2015-08-07       Impact factor: 7.327

Review 10.  ICD-10 codes used to identify adverse drug events in administrative data: a systematic review.

Authors:  Corinne M Hohl; Andrei Karpov; Lisa Reddekopp; Mimi Doyle-Waters; Jürgen Stausberg
Journal:  J Am Med Inform Assoc       Date:  2013-11-12       Impact factor: 4.497

  10 in total
  5 in total

Review 1.  Machine Learning in Causal Inference: Application in Pharmacovigilance.

Authors:  Yiqing Zhao; Yue Yu; Hanyin Wang; Yikuan Li; Yu Deng; Guoqian Jiang; Yuan Luo
Journal:  Drug Saf       Date:  2022-05-17       Impact factor: 5.228

Review 2.  Intelligent Telehealth in Pharmacovigilance: A Future Perspective.

Authors:  Heba Edrees; Wenyu Song; Ania Syrowatka; Aurélien Simona; Mary G Amato; David W Bates
Journal:  Drug Saf       Date:  2022-05-17       Impact factor: 5.228

3.  Precision Dosing of Doxapram in Preterm Infants Using Continuous Pharmacodynamic Data and Model-Based Pharmacokinetics: An Illustrative Case Series.

Authors:  Jarinda A Poppe; Willem van Weteringen; Lotte L G Sebek; Catherijne A J Knibbe; Irwin K M Reiss; Sinno H P Simons; Robert B Flint
Journal:  Front Pharmacol       Date:  2020-05-12       Impact factor: 5.810

4.  Development and Implementation of an e-Trigger Tool for Adverse Drug Events in a Swiss University Hospital.

Authors:  Amina El Saghir; Georgios Dimitriou; Miriam Scholer; Ioanna Istampoulouoglou; Patrick Heinrich; Klaus Baumgartl; René Schwendimann; Stefano Bassetti; Anne Leuppi-Taegtmeyer
Journal:  Drug Healthc Patient Saf       Date:  2021-12-24

5.  Machine learning risk prediction model for acute coronary syndrome and death from use of non-steroidal anti-inflammatory drugs in administrative data.

Authors:  Girish Dwivedi; Frank M Sanfilippo; Juan Lu; Ling Wang; Mohammed Bennamoun; Isaac Ward; Senjian An; Ferdous Sohel; Benjamin J W Chow
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.